Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+6.5%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$43.2B
AUM Growth
+$531M
(+1.2%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
19.93%
Holding
2,596
New
336
Increased
982
Reduced
987
Closed
267
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$558M |
| 2 |
Amazon
AMZN
|
$535M |
| 3 |
Tesla
TSLA
|
$517M |
| 4 |
Netflix
NFLX
|
$372M |
| 5 |
Adobe
ADBE
|
$369M |
Top Sells
| 1 |
Broadcom
AVGO
|
$494M |
| 2 |
Bristol-Myers Squibb
BMY
|
$435M |
| 3 |
Micron Technology
MU
|
$372M |
| 4 |
CrowdStrike
CRWD
|
$365M |
| 5 |
Wells Fargo
WFC
|
$336M |
Sector Composition
| 1 | Technology | 24.93% |
| 2 | Healthcare | 15.48% |
| 3 | Financials | 15.24% |
| 4 | Consumer Discretionary | 12.68% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VZLA
2276
Vizsla Silver
VZLA
$1.28B
| $54.5K | ﹤0.01% |
+31,900
| New | +$54.5K |
|
2277
Cambium Networks
CMBM
$18.4M
| $53.9K | ﹤0.01% |
83,600
| – | – |
|
|
SLRN
2278
DELISTED
ACELYRIN
SLRN
| $52.4K | ﹤0.01% |
16,700
-65,400
| -80% | -$205K |
|
2279
Karyopharm Therapeutics
KPTI
$57.2M
| $51.8K | ﹤0.01% |
5,107
+3,027
| +146% | +$30.7K |
|
2280
Century Therapeutics
IPSC
$43.6M
| $51.5K | ﹤0.01% |
+51,000
| New | +$51.5K |
|
|
TSVT
2281
DELISTED
2seventy bio
TSVT
| $50.9K | ﹤0.01% |
17,300
+2,100
| +14% | +$6.17K |
|
2282
Blue Ridge Bankshares
BRBS
$374M
| $50.6K | ﹤0.01% |
+15,700
| New | +$50.6K |
|
2283
Custom Truck One Source
CTOS
$1.38B
| $50.5K | ﹤0.01% |
10,500
-46,900
| -82% | -$226K |
|
2284
CureVac
CVAC
$1.21B
| $48.4K | ﹤0.01% |
+14,200
| New | +$48.4K |
|
|
ELEV
2285
DELISTED
Elevation Oncology
ELEV
| $47.5K | ﹤0.01% |
84,400
+27,300
| +48% | +$15.4K |
|
|
DDL
2286
Dingdong
DDL
$470M
| $46.9K | ﹤0.01% |
+14,300
| New | +$46.9K |
|
2287
Sundial Growers
SNDL
$638M
| $46.7K | ﹤0.01% |
+26,100
| New | +$46.7K |
|
2288
Xeris Biopharma Holdings
XERS
$1.27B
| $46.6K | ﹤0.01% |
+13,741
| New | +$46.6K |
|
|
ZH
2289
Zhihu
ZH
$428M
| $45.9K | ﹤0.01% |
12,966
-600
| -4% | -$2.12K |
|
|
ATYR
2290
aTyr Pharma
ATYR
$550M
| $44.3K | ﹤0.01% |
12,250
-66,100
| -84% | -$239K |
|
2291
Babcock & Wilcox
BW
$215M
| $43.8K | ﹤0.01% |
26,734
+13,800
| +107% | +$22.6K |
|
2292
Lineage Cell Therapeutics
LCTX
$279M
| $43.7K | ﹤0.01% |
86,964
+65,864
| +312% | +$33.1K |
|
2293
IHS Holding
IHS
$2.44B
| $42K | ﹤0.01% |
+14,400
| New | +$42K |
|
|
CMRX
2294
DELISTED
Chimerix, Inc.
CMRX
| $41.4K | ﹤0.01% |
11,900
-20,600
| -63% | -$71.7K |
|
2295
Gaotu Techedu
GOTU
$877M
| $41.2K | ﹤0.01% |
+18,800
| New | +$41.2K |
|
|
OTLY
2296
Oatly Group
OTLY
$524M
| $40.6K | ﹤0.01% |
+3,065
| New | +$40.6K |
|
|
ALLK
2297
DELISTED
Allakos
ALLK
| $40.1K | ﹤0.01% |
33,100
-29,400
| -47% | -$35.6K |
|
2298
Atossa Therapeutics
ATOS
$102M
| $40K | ﹤0.01% |
42,400
+28,900
| +214% | +$27.3K |
|
2299
Arbutus Biopharma
ABUS
$805M
| $39.2K | ﹤0.01% |
12,000
-1,200
| -9% | -$3.92K |
|
2300
Leslie's
LESL
$64.6M
| $39K | ﹤0.01% |
+17,500
| New | +$39K |
|